Because,
The FDA requires that the potency assays that are used for a phase 3 clinical trial, are suitable for use as potency assays for phase 3 trials. ( They are approved as potency assays for the trial only ) This does not mean they are suitable for commercial sales or approved or appropriate for commercial sales, or that they should not be further improved after the phase 3 trial.
Because, The FDA requires that the potency assays that are used...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
-0.003(0.20%) |
Mkt cap ! $1.478B | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.31 | $1.28 | $781.4K | 606.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 118554 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.28 | 46202 | 12 |
View Market Depth
| Last trade - 12.24pm 05/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |